Alterity Therapeutics ATHE
NASDAQ ATHE
$2.39 -0.04 (-1.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) Accumulated Expenses (2010 - 2025)

Updated

Alterity Therapeutics' Accumulated Expenses was $89,174 in the quarter ended Jun 30, 2025, down 18.5% from $109,440 a year earlier.

Analysis

Alterity Therapeutics (ATHE) Accumulated Expenses (2010 - 2025) Analysis & Trends

  • In earlier years, Accumulated Expenses was $109,440 in the year ended Jun 30, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Alterity Therapeutics 41.90 Mn -41.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 90,968.49
Jun 30, 2024 110,441.85
Jun 30, 2023 222,126.00
Jun 30, 2013 2.13 Mn
Jun 30, 2011 2.10 Mn
Jun 30, 2010 2.11 Mn
API Access

Alterity Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ATHE&period=max&api_key=YOUR_API_KEY